These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4838506)

  • 21. A comparative study on the metabolism of 3,4-dimethoxyphenylethylamine-C 14 and mescaline-C 14 by rabbit, mouse and rat brain homogenates.
    Shah NS
    Arch Int Pharmacodyn Ther; 1971 Oct; 193(2):357-61. PubMed ID: 5119220
    [No Abstract]   [Full Text] [Related]  

  • 22. Mescaline and homoveratrylamine as discriminative stimuli in rats.
    Bueno OF
    Acta Physiol Lat Am; 1975; 25(1):77-9. PubMed ID: 1221818
    [No Abstract]   [Full Text] [Related]  

  • 23. Alteration by pretreatment with iproniazid and an inactive mescaline analogue of a behaviour change induced by mescaline.
    Smythies JR; Johnston VS; Bradley RJ
    Nature; 1967 Oct; 216(5111):196-7. PubMed ID: 6057240
    [No Abstract]   [Full Text] [Related]  

  • 24. Excitatory and inhibitory effects of mescaline on shuttle avoidance in the rat.
    Bridger WH; Mandel IJ
    Biol Psychiatry; 1971; 3(4):379-85. PubMed ID: 5163821
    [No Abstract]   [Full Text] [Related]  

  • 25. Preliminary studies of the sodium borohydride stabilizable binding of phenylethylamine and tyramine to brain preparations.
    Ungar F; Mosnaim AD; Ungar B; Wolf ME
    Res Commun Chem Pathol Pharmacol; 1978 Mar; 19(3):427-34. PubMed ID: 653100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences between amine oxidases deaminating mescaline and the structurally related 3,4-dimethoxyphenylethyl amine.
    Huszti Z; Borsy J
    Biochem Pharmacol; 1966 Apr; 15(4):475-80. PubMed ID: 5954979
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of chronic administration of beta-(3,4-dimethoxyphenyl)-ethylamine and beta-(3,4,5-trimethoxyphenyl)-ethylamine on the climbing rope performance of rats.
    Carlini EA; Teresa M; Silva A; Cesare LC; Endo RM
    Med Pharmacol Exp Int J Exp Med; 1967; 17(6):534-42. PubMed ID: 5631690
    [No Abstract]   [Full Text] [Related]  

  • 28. Autoradiographic studies on the distribution of 3H-2,3,4-trimethoxy-beta-phenylethylamine in the mouse.
    Korr H; Seiler N
    Psychopharmacologia; 1976; 46(1):53-8. PubMed ID: 1257367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of dimethoxyphenylethylamine and mescaline on classical conditioning in rats as measured by the potentiated startle response.
    Bridger WH; Mandel IJ
    Life Sci; 1967 Apr; 6(7):775-81. PubMed ID: 6031262
    [No Abstract]   [Full Text] [Related]  

  • 30. Does increasing stress change the behavioral action of mescaline from disruption to facilitation?
    Gorelick DA; Bridger WH
    Psychopharmacologia; 1975 Nov; 44(3):307-9. PubMed ID: 1239785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic and neurochemical studies on N-propargyl-2-phenylethylamine, a prodrug of 2-phenylethylamine.
    Rao TS; Baker GB; Coutts RT
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):25-32. PubMed ID: 3627289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral disinhibition by mescaline.
    Carder B; Cheng RS
    Life Sci; 1976 Mar; 18(6):585-91. PubMed ID: 1263741
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic fate of beta-(3,4-dimethoxyphenyl)-ethylamine in man.
    Charalampous KD; Tansey LW
    J Pharmacol Exp Ther; 1967 Feb; 155(2):318-29. PubMed ID: 6025522
    [No Abstract]   [Full Text] [Related]  

  • 34. Placental transfer and tissue distribution of mescaline- 14 C in the mouse.
    Shah NS; Neely AE; Shah KR; Lawrence RS
    J Pharmacol Exp Ther; 1973 Feb; 184(2):489-93. PubMed ID: 4688184
    [No Abstract]   [Full Text] [Related]  

  • 35. Peripheral tissue distribution, brain distribution, metabolism, placental transfer, & fetal distribution of mescaline- 14 C in monkeys.
    Taska RJ
    Tex Med; 1972 Sep; 68(9):56-67. PubMed ID: 4627169
    [No Abstract]   [Full Text] [Related]  

  • 36. Disposition of 14C-mescaline by rabbit lung.
    Roth RA; Roth JA; Gillis CN
    J Pharmacol Exp Ther; 1977 Feb; 200(2):394-401. PubMed ID: 839444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective effects of phenylethylamine on central catecholamines: a comparative study with amphetamine.
    Karoum F; Speciale SG; Chuang LW; Wyatt RJ
    J Pharmacol Exp Ther; 1982 Nov; 223(2):432-9. PubMed ID: 7131298
    [No Abstract]   [Full Text] [Related]  

  • 38. Alteration of behavioural changes induced by 3,4,5-trimethoxyphenylethylamine (mescaline) by pretreatment with 2,4,5-trimethoxyphenylethylamine. A self-experiment.
    Dittrich A
    Psychopharmacologia; 1971; 21(3):229-37. PubMed ID: 5095413
    [No Abstract]   [Full Text] [Related]  

  • 39. Neurolepticlike actions of l-methadone: effect on mescaline-induced altered behavior and on tissue levels of mescaline in mice.
    Shah NS; Hudnall SD; May D; Eargle D; Yates J
    Biol Psychiatry; 1979 Aug; 14(4):587-94. PubMed ID: 486615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection.
    Oldendorf WH
    Am J Physiol; 1971 Dec; 221(6):1629-39. PubMed ID: 5124307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.